Presentation of three palliative care patients who were given ketamine as an analgesic and subsequently developed significant and debilitating urological symptoms. In one patient there was resolution of symptoms following cessation of ketamine, but some symptoms persisted until death in the other two. Possible mechanisms for damage to the urothelium by ketamine are suggested.
Gregoire, M-C. , Maclellan, D., Finley , A.A pediatric case of ketamine-associated cystitis . Urology2008 ; 71: 1232- 1233 [Letter-to-the-Editor].
5.
Twycross, R, Wilcock, A, (eds) in: Palliative care formulary, 3rd ed.; 2007. Nottingham, UK: Palliativedrugs.com Ltd, pp. 443-449.
6.
WHOhttp://www.whocancerpain.wisc.edu/eng/15_2/adjuvants.html (accessed 25 June 2009).
7.
Muetzelfeldt, L., Kamboja, SK, Ressa , H., Taylora, J., Morgana, CJA, Currana, HVJourney through the K-hole: Phenomenological aspects of ketamine use. Drug Alcohol Depend95: 219-229.
8.
Nemitz, DG, Westmoreland, C., George, E., Kapwijk, J., Watts, N.Toxic effects of ketamine hydrochloride (VetelarTMV) on cultures of marmoset bladder epithelial cells and whole rat bladders in vitro. Proceedings of the 4th World Congress on Alternatives and Animal Use in Life Sciences, New Orleans, August 11-15, 2002.
